3Spine Completes First U.S. Surgeries

3Spine announced completion of the first series of U.S. surgeries in the BalancedBack Total Joint Replacement Investigational Device Exemption (IDE) pivotal clinical trial. All patients enrolled in the trial will receive the MOTUS device and will be propensity-matched against patients prospectively enrolled in 3Spine's real-world...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us